Inflammatory protein sPLA2-IIA abrogates TNFα-induced apoptosis in human astroglioma cells: Crucial role of ERK

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 12, 2009, Pages 1837-1847

  Ibeas, Elvira ^a   Fuentes, Lucía ^a   Martín, Rubén ^a   Hernández, Marita ^a   Nieto, María Luisa ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Apoptosis; Astrocytoma cells; Cytokines; Protein kinases; Secreted phospholipase A2; Tumor necrosis factor

Indexed keywords

CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP IIA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CARCINOGENESIS; CELL STIMULATION; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MITOGENESIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; ASTROCYTOMA; CELL LINE, TUMOR; CYCLOOXYGENASE 2; ENZYME INDUCTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GROUP II PHOSPHOLIPASES A2; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 71749118336     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.10.004     Document Type: Article

References (46)

1. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (2006) S232-S240
2. Rakoff-Nahoum S. Why cancer and inflammation?. Yale J. Biol. Med. 79 (2006) 123-130
3. Morantz R.A., Wood G.W., Foster M., Clark M., and Gollahon K. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J. Neurosurgery. 50 (1979) 305-311
4. Kostianovsky A. Astrocyte-mediated regulation of human CNS inflammation. Clin. Immunol. 123 (2007) S184
5. Chen G.G., Chu Y.S., Chak E.C., Leung B.C., and Poon W.S. Induction of apoptosis in glioma cells by molecules released from activated macrophages. J. Neurooncol. 57 (2002) 179-186
6. Chung I.Y., and Benveniste E.N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144 (1990) 2999-3007
7. Jensen M.D., Sheng W., Simonyi A., Johnson G.S., Sun A.Y., and Sun G.Y. Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes. Neurochem. Int. 55 (2009) 362-368
8. Menschikowski M., Hagelgans A., and Siegert G. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?. Prostaglandins Other Lipid Mediat. 79 (2006) 1-33
9. Sun G.Y., and Hu Z.Y. Stimulation of phospholipase A2 expression in rat cultured astrocytes by LPS, TNF alpha and IL-1 beta. Prog. Brain Res. 105 (1995) 231-238
10. Tong W., Hu Z.Y., and Sun G.Y. Stimulation of group II phospholipase A2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNF alpha, and IL-1 beta. Interactive effects. Mol. Chem. Neuropathol. 25 (1995) 1-17
11. Adibhatla R., and Hatcher J. Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. Brain Res. 1134 (2007) 199-205
12. Moses G.S., Jensen M.D., Lue L.F., Walker D.G., Sun A.Y., Simonyi A., and Sun G.Y. Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J. Neuroinflammation 3 (2006) 28
13. Laye J.L., and Gill J.H. Phospholipase A2 expression in tumours: a target for therapeutic intervention?. Drug Discov. Today 8 (2003) 710-716
14. Granata F., Frattini A., Loffredo S., Del Prete A., Sozzani S., Marone G., and Triggiani M. Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages. Eur. J. Immunol. 36 (2006) 1938-1950
15. Hernandez M., Burillo S.L., Crespo M.S., and Nieto M.L. Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. J. Biol. Chem. 273 (1998) 606-612
16. 2+ mobilization in the human astrocytoma cell line 1321N1 by a mechanism independent of its catalytic activity. Biochem. Biophys. Res. Commun. 260 (1999) 99-104
17. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
18. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
19. Hehlgans T., and Pfeffer K. The intriguing biology of the tumor necrosis factor/tumor necrosis factor receptor superfamily: players, rules and the games. Immunology 115 (2005) 1-20
20. Sabourin L.A., Tamai K., Seale P., Wagner J., and Rudnicki M.A. Caspase 3 cleavage of the Ste20-related kinase SLK releases and activates an apoptosis-inducing kinase domain and an actin-disassembling region. Mol. Cell. Biol. 20 (2000) 684-696
21. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107 (2001) 241-246
22. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes. Dev. 18 (2004) 2195-2224
23. Lieb K., Fiebich B.L., Schaller H., Berger M., and Bauer J. Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. J. Neurochem. 67 (1996) 2039-2044
24. Marcus J.S., Karackattu S.L., Fleegal M.A., and Sumners C. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia 41 (2003) 152-160
25. Hernández M., Bayón Y., Sánchez Crespo M., and Nieto M.L. Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factor-alpha: phosphorylation of cytosolic phospholipase A2 and transactivation of cyclooxygenase-2. J. Neurochem. 73 (1999) 1641-1649
26. Van Linden A.A., Cottin V., Leu C., and Riches D.W. Phosphorylation of the membrane proximal region of tumor necrosis factor receptor CD120a (p55) at ERK consensus sites. J. Biol. Chem. 275 (2000) 6996-7003
27. Pernas P., Masliah J., Olivier J.L., Salvat C., and Bereziat G. Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release. Biochem. Biophys. Res. Commun. 178 (1991) 1298-1305
28. Frankel S.K., Van Linden A.A., and Riches D.W. Heterogeneity in the phosphorylation of human death receptors by p42(mapk/erk2). Biochem. Biophys. Res. Commun. 288 (2001) 313-320
29. Yano M., Kishida E., Iwasaki M., Kojo S., and Masuzawa Y. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. J. Nutr. 130 (2000) 1095-1101
30. Zuckerbraun B.S., Billiar T.R., Otterbein S.L., Kim P.K., Liu F., Choi A.M., Bach F.H., and Otterbein L.E. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J. Exp. Med. 198 (2003) 1707-1716
31. Al-Rasheed N.M., Willars G.B., and Brunskill N.J. C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. J. Am. Soc. Nephrol. 17 (2006) 986-995
32. Akca H., Akan S.Y., Yanikoglu A., and Ozed O.N. Suppression of TNF-alpha mediated apoptosis by EGF in TNF-alpha sensitive human cervical carcinoma cell line. Growth Factors 21 (2003) 31-39
33. Yagami T., Ueda K., Asakura K., Hata S., Kuroda T., Sakaeda T., Takasu N., Tanaka K., Gemba T., and Hori Y. Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. Mol. Pharmacol. 61 (2002) 114-126
34. 2 induces neuronal cell death via apoptosis. J. Neurochem. 81 (2002) 449-461
35. DeCoster M.A. Group III secreted phospholipase A2 causes apoptosis in rat primary cortical neuronal cultures. Brain Res 988 (2003) 20-28
36. DeCoster M.A., Lambeau G., Lazdunski M., and Bazan N.G. Secreted phospholipase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J. Neurosci. Res. 67 (2002) 634-645
37. Fonteh A.N., Marion C.R., Barham B.J., Edens M.B., Atsumi G., Samet J.M., High K.P., and Chilton F.H. Enhancement of mast cell survival: a novel function of some secretory phospholipase A(2) isotypes. J. Immunol. 167 (2001) 4161-4171
38. Carpenter C.L. Actin cytoskeleton and cell signaling. Crit. Care Med. 28 (2000) N94-99
39. Kim S.G., Soltysiak K.A., Gao Z.G., Chang T.S., Chung E., and Jacobson K.A. Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. Biochem. Pharmacol. 65 (2003) 923-931
40. Gambelli F., Di P., Niu X., Friedman M., Hammond T., Riches D.W., and Ortiz L.A. Phosphorylation of tumor necrosis factor receptor 1 (p55) protects macrophages from silica-induced apoptosis. J. Biol. Chem. 279 (2004) 2020-2029
41. Radeff-Huang J., Seasholtz T.M., Chang J.W., Smith J.M., Walsh C.T., and Brown J.H. Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. J. Biol. Chem. 282 (2007) 863-870
42. Harper K.A., and Tyson-Capper A.J. Complexity of COX-2 gene regulation. Biochem. Soc. Trans. 36 (2008) 543-545
43. Zhang Z., Sheng H., Shao J., Beauchamp R.D., and DuBois R.N. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia 2 (2000) 523-530
44. Li Z., Jansen M., Pierre S.R., and Figueiredo-Pereira M.E. Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation. Int. J. Biochem. Cell. Biol. 35 (2003) 547-552
45. Yamashita M., Shinnakasu R., Asou H., Kimura M., Hasegawa A., Hashimoto K., Hatano N., Ogata M., and Nakayama T. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J. Biol. Chem. 280 (2005) 29409-29419
46. Vial E., and Marshall C.J. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J. Cell. Sci. 116 (2003) 4957-4963